Achieve Life Sciences, Inc. ACHV
Set alert
6.74 USD +0.13 +1.97%
As of Nov 3, 1:47 PM ET
6.63 Day range 6.89
2.62 52-week range 8.64
- YTD
- +35.61%
- 1 year
- +31.90%
- Open
- 6.69
- Prev close
- 6.61
- Mkt cap
- 694.91M
- Vol
- 336.55K
- Avg vol
- 1.46M
- EPS
- -1.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.63
- High
- 6.89
- Forward P/E
- -3.30
- Beta
- 1.58
- Short ratio
- 23.98
- Inst. own
- 59.60%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.53
- 200-d avg
- 4.66
- 1y target
- 16.44
6M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 27, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| RSI: Overbought | Aug 26, 2026 | 2 months ago |
| RSI: Overbought | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| MACD: Sell Signal | May 19, 2026 | 5 months ago |
| RSI: Overbought | May 8, 2026 | 5 months ago |
Analyst view
Price target (mean) 16.44 +144.0% upside
Now 6.74
- Target (low)
- 10.00
- Target (mean)
- 16.44
- Target (high)
- 30.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy1
- Buy7
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.36 | -0.41 – -0.31 | -0.26 | -38.5% | 0 | 0.0% | 6 |
| Next quarter | -0.348 | -0.42 – -0.31 | -0.26 | -33.9% | 0 | 0.0% | 5 |
| Current year | -1.25 | -1.30 – -1.18 | -1.50 | +17.0% | 0 | 0.0% | 6 |
| Next year | -1.16 | -1.41 – -0.86 | -1.25 | +6.5% | 0 | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | Rodman & Renshaw | Initiated | — | Buy |
| Aug 15, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 13, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 17, 2024 | JonesTrading | Initiated | — | Buy |
| Apr 1, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 5, 2024 | Lake Street | Maintained | Buy | Buy |
| Dec 12, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| May 31, 2023 | Lake Street | Maintained | Buy | Buy |
| May 10, 2023 | Lake Street | Maintained | Buy | Buy |
| Mar 17, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Nov 16, 2022 | Maxim Group | Maintained | — | Buy |
| Oct 4, 2021 | Alliance Global Partners | Initiated | — | Buy |
| Jun 23, 2021 | Oppenheimer | Initiated | — | Outperform |
| Sep 17, 2020 | Lake Street | Initiated | — | Buy |
| Feb 25, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Jun 14, 2019 | Maxim Group | Initiated | — | Buy |